The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders

Biological Psychiatry

Volumn 46, Issue 11, 1999, Pages 1509-1522

  Heim, Christine ^a   Nemeroff, Charles B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; Corticotropin releasing factor; Depression; Development; Stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

ADULTHOOD; AFFECTIVE NEUROSIS; AMYGDALOID NUCLEUS; ANXIETY NEUROSIS; BEHAVIOR; CHILDHOOD; CONFERENCE PAPER; DEPRESSION; ENVIRONMENTAL FACTOR; EXPERIENCE; GENETIC PREDISPOSITION; HEREDITY; HUMAN; LOCUS CERULEUS; MENTAL DISEASE; MODEL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STRESS;

ANXIETY; BRAIN; CHILD; CHILD DEVELOPMENT; CORTICOTROPIN-RELEASING HORMONE; HUMANS; LIFE CHANGE EVENTS; MOOD DISORDERS; STRESS, PSYCHOLOGICAL;

EID: 0032730256     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00224-3     Document Type: Conference Paper

References (123)

1. Altemus M., Pigott T., Kalogeras K.T., Demitrack M., Dubbert B., Murphy D.L., et al. Abnormalities in the regulation of vaspressin and corticotropin-releasing factor secretion in obsessive-compulsive disorder. Arch Gen Psychiatry. 49:1992;9-20.
2. Altemus M., Swedo S.E., Leonard H.L., Richter D., Rubinow D.R., Potter W.Z., et al. Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. Arch Gen Psychiatry. 51:1994;794-803.
3. Amsterdam J.D., Winokur A., Abelman E., Lucki I., Rickels K. Cosyntropin (ACTH alpha 1-24) stimulation test in depressed patients and healthy subjects. Am J Psychiatry. 140:1983;907-908.
4. Amsterdam J.D., Maislin G., Winoku A., Berwish N., Kling M., Gold P. The oCRH test before and after clinical recovery from depression. J Affect Disord. 14:1988;213-222.
5. Antoni F.A., Palkovits T., Makara G.B., Linton E.A., Lowry P.J., Kiss J.Z. Immunoreactive corticotropin-releasing hormone in the hypothalamoinfundibular tract. Neuroendocrinology. 36:1983;415-423.
6. Arató M., Bánki C.M., Bisette G., Nemeroff C.B. Elevated CSF CRF in suicide victims. Biol Psychiatry. 25:1989;355-359.
7. Arborelius L., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol. 160:1999;1-12.
8. Axelson D.A., Doraiswamy M.P., McDonald W.M., Boyko O.B., Tupier L.A., Patterson L.J., et al. Hypercortisolemia and hippocampal changes in depression. Psychiatry Res. 47:1993;163-173.
9. Bánki C.M., Bissette G., Arató M., O'Connor L., Nemeroff C.B. Cerebrospinal fluid corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry. 144:1987;873-877.
10. Bánki C.M., Karmaksi L., Bissette G., Nemeroff C.B. Cerebrospinal fluid neuropeptides in mood disorder and dementia. J Affect Disord. 25:1992;39-46.
11. Bánki C.M., Karmaksi L., Bissette G., Nemeroff C.B. CSF corticotropin-releasing hormone and somatostatin in major depression response to antidepressant treatment and relapse . Eur Neuropharmacol. 2:1992;107-113.
12. Beyer H.S., Matta S.G., Sharp B.M. Regulation of the messenger ribonucleic acid for corticotropin-releasing factor in the paraventricular nucleus and other brain sites of the rat. Endocrinology. 123:1988;2117-2123.
13. Board F., Wadeson R., Persky H. Depressive affect and endocrine function Blood levels of adrenal cortex and thyroid hormones in patients suffering from depressive reactions . Arch Neurol Psychiatry. 78:1957;612-620.
14. Brady L.S., Gold P., Herkenham M., Lynn A., Whitfield H.J. The antidepressants fluoxetine, idazoxan, and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain Therapeutic inplications . Brain Res. 572:1992;117-125.
15. Bremner J.D., Southwick S.M., Johnson D.R., Yehuda R., Charney D.S. Childhood physical abuse and combat-related posttraumatic stress disorder in Vietnam veterans. Am J Psychiatry. 150:1993;235-239.
16. Bremner J.D., Randall P., Scott T.M., Bronen R.A., Seibyl J.P., Southwick S.M., et al. Magnetic resonance imaging-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry. 152:1995;973-981.
17. Bremner J.D., Licino J., Darnell A., Krystal J.H., Owens M.J., Southwick S.M., et al. Elevated CSF corticotropin-releasing factor concentrations in PTSD. Am J Psychiatry. 154:1997;624-629.
18. Browne A., Finkelhor D. Impact of childhood sexual abuse. Psychol Bull. 99:1986;66-77.
19. Butler P.D., Weiss J.M., Stout J.C., Nemeroff C.B. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci. 10:1990;176-183.
20. Buwalda B., de Boer S.F., van Kalkeren A.A., Koolhaas J.M. Physiological and behavioral effects of of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat. Psychoneuroendocrinology. 22:1997;297-309.
21. A and central benzodiazepine receptor levels and novelty-induced fearfulness in the rat. J Neurosci.
22. Carroll B.J., Feinberg M., Greden J.F., Tarika J., Albala A.A., Haskett R.F., et al. A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry. 38:1981;15-22.
23. Chalmers D.T., Lovenberg T.W., Grigoriadis D.E., Behan D.P., De Souza E.B. Corticotropin-releasing factor receptors From molecualr biology to drug design . Trends Pharmacol Sci. 17:1996;166-172.
24. Chappell P.B., Smith M.A., Kilts C.D., Bissette G., Ritchie J.C., Andersen C., et al. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete brain regions after acute and chronic stress. J Neurosci. 6:1986;2908-2914.
25. Connor K.M., Davidson J.R.T. The role of serotonin in posttraumatic stress disorder. CNS Spectrums. 3:1998;43-51.
26. Coplan J.D., Andrews M.W., Rosenblum L.A., Owens M.J., Friedman S., Gorman J.M., et al. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early life stressors Implications for the pathophysiology of mood and anxiety disorders . Proc Natl Acad Sci U S A. 93:1996;1619-1623.
27. Curtis G.C., Abelson J.L., Gold P.W. Adrenocorticotropic and hormone and cortisol responses to corticotropin-releasing hormone Changes in panic disorder and effects of alprazolam treatment . Biol Psychiatry. 41:1997;76-85.
28. Dallman M.F., Akana S., Cascio C.S., Darlington D.N., Jacobson L., Levin N., et al. Regulation of ACTH secretion Variations on a theme of B . Rec Prog Horm Res. 43:1987;113-173.
29. DeBellis M.D., Gold P., Geracioti T.D., Listwak S.J., Kling M.A. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopression in patients with major depression. Am J Psychiatry. 150:1993;656-657.
30. DeBellis M.D., Chrousos G.P., Dorn L.D., Burke L., Helmers K., Kling M.A., et al. Hypothalamic pituitary adrenal dysregulation in sexually abused girls. J Clin Endocrinol Metab. 78:1994;249-255.
31. DeKloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev. 19:1991;269-301.
32. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration Is CRF a mediator of anxiety or stress responses? Brain Res Rev. 15:1990;71-100.
33. Freud S. General theory on neuroses. Freud A. The Standard Edition of the Complete Psychological Works of Sigmund Freud. 1895;Hogarth, London.
34. Geracioti T.D., Loosen P.T., Orth D.N. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression. Biol Psychiatry. 42:1997;166-174.
35. Gold P.W., Chrousos G., Kellner C., Post R., Roy A., Augerinos P., et al. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psychiatry. 141:1984;619-627.
36. Goldstein S., Halbreich U., Asnis G., Endicott J., Alvir J. The hypothalamic-pituitary-adrenal system in panic disorder. Am J Psychiatry. 144:1987;1320-1323.
37. Gray T.S., Carney M.E., Magnuson D.J. Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus Possible role in stress-induced adrenocorticotropin release . Neuroendocrinology. 50:1989;433-446.
38. Gurvits T.G., Shenton M.R., Hokama H., Ohta H., Lasko N.B., Gilberson M.W., et al. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry. 40:1996;193-199.
39. Heim C., Graham Y.P., Heit S.C., Bonsall R., Miller A.H., Nemeroff C.B. Increased sensitivity of the hypothalamic-pituitary-adrenal axis to psychosocial stress in adult survivors of childhood abuse. Soc Neurosci Abst. 28:1998;201.12.
40. Heim C., Ehlert U., Hanker J.P., Hellhammer D.H. Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain. Psychosom Med. 60:1998;309-318.
41. Heuser I., Yassouridis A., Holsboer F. The combined dexamethasone/CRF test A refined laboratory test for psychiatric disorders . J Psychiatr Res. 28:1994;341-356.
42. Hitchcock J., Davis M. Lesions of the amygdala, but not of the cerebellum block conditioned fear measured with the potentiated startle paradigm. Behav Neurosci. 100:1996;11-22.
43. Holsboer F. The hypothalamic-pituitary-adrenocortical system. Paykel E.S. Handbook of Affective Disorders. 1991;267-287 Churchill, Livingston.
44. Holsboer F., Gerken A., Stalla G.K., Mueller O.A. ACTH, cortisol and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery. Biol Psychiatry. 20:1985;276-286.
45. Holsboer F., von Bardeleben U., Buller R., Heuser I., Steiger A. Stimulation response to corticotropin-releasing hormone (CRH) in patients with depression, alcoholism and panic disorder. Horm Metab Res. 16:1987;80-88.
46. Huot RL, Smith M, Plotsky PM (July 1997): Alterations of maternal-infant interaction as a result of maternal separation in Long Evans rats and its behavioral and neuroendocrine consequences. Presented at the 28th Congress of the International Society for Psychoneuroendocrinology, San Francisco.
47. Insel T.R., Kalin N.H., Guttmacher L.B., Cohen R.M., Murphy D.L. The dexamethasone suppression test in patients with primary obsessive compulsive disorder. Psychiatry Res. 6:1982;153-160.
48. Jolkkonen J., Lepola U., Bissette G., Nemeroff C.B., Riekkinen. CSF corticotropin-releasing factor is not affected in panic disorder. Biol Psychiatry. 33:1993;136-138.
49. Kalin N.H. Behavioral and endocrine studies of corticotropin-releasing hormone in primates. De Souza E.B., Nemeroff C.B. Corticotropin-Releasing Factor Band and Clinical Studies of a Neuropeptide . 1990;275-289 CRC Press, Boca Raton, FL.
50. Kaufman J., Birmaher B., Perel J., Dahl R.E., Moreci P., Nelson B., et al. The corticotropin-releasing hormone challenge in depressed abused, depressed nonabused, and normal control children. Biol Psychiatry. 42:1997;669-679.
51. Kendler K.S., Kessler R.C., Neale M.C., Heath A.C., Eaves L.J. The prediction of major depression in women Toward an integrated model . Am J Psychiatry. 150:1993;1139-1148.
52. Kendler K.S., Kessler R.C., Walters E.E., MacLean C., Neale M.C., Heath A.C., et al. Stressful life events, genetic liability and onset of an episode of major depression. Am J Psychiatry. 152:1995;833-842.
53. Kessler R.C. The effects of stressful life events on depression. Annu Rev Psychol. 48:1997;191-214.
54. Kessler R.C., Magee W.J. Childhood adversities and adult depression Basic patterns of association in a US national survey . Psychol Med. 23:1993;679-690.
55. Kling M.A., Roy A., Doran A.R., Calabrese J.R., Rubinow D.R., Whitfield H.J., et al. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression Potential clinical implications . J Clin Endocrinol Metab. 71:1991;260-271.
56. Koob G.F., Heinrichs S.C., Menzaghi F., Pich E.M., Britton K.T. Corticotropin-releasing factor, stress and behavior. Semin Neurosci. 6:1994;221-229.
57. Kosten T.R., Mason J.W., Giller E.L., Harkness L. Sustained urinary norepinephrine and epinephrine elevation in posttraumatic stress disorder. Psychoneuroendocrinology. 12:1987;13-20.
58. Krishnan R.R., Doraiswamy P.M., Lurie S.M., Figiel G.S., Husain M.M., Boyko O.B., et al. Pituitary size in depression. J Clin Endocrinol Metab. 72:1991;256-259.
59. Ladd C.O., Owens M.J., Nemeroff C.B. Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. Endocrinology. 137:1996;1212-1218.
60. Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Meaney MJ, Plotsky PM (in press): Long-term behavioral and neuroendocrine adaptations to adverse early experience. In: Mayer E, Saper C, editors. Progress in Brain Research: The Biological Basis for Mind Body Interactions. Amsterdam: Elsevier.
61. LeDoux J.E. The amygdala Contributions to fear and stress . Semin Neurosci. 6:1994;231-237.
62. Liang K.C., Lee E.H.Y. Intra-amygdala injections of corticotropin-releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats. Psychopharmacology (Berl). 96:1988;232-236.
63. Liu D, Caldji C, Sharma S, Plotsky PM, Meaney MJ (in press): Influence of neonatal rearing condition on stress-induced hypothalamic-pituitary-adrenal responses and norepinephrine release in the hypothalamic paraventricular nucleus. J Neurosci.
64. McCauley J., Kern D.E., Kolodner K., Dill L., Schroeder A.F., DeChant, et al. Clinical characteristics of women with a history of childhood abuse. JAMA. 277:1997;1362-1368.
65. McCranie E.W., Hyer L.A., Boudewyns P.A., Woods M.G. Negative parenting behavior, combat exposure and PTSD symptom severity Test of a person-event interaction model . J Nerv Ment Dis. 180:1992;431-438.
66. McEwen B.S. Protective and damaging effects of stress mediators. N Engl J Med. 338:1998;171-179.
67. Melia K.R., Duman R.S. Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc Natl Acad Sci U S A. 88:1991;8382-8386.
68. Mullen P.E., Martin J.L., Anderson J.C., Romans S.E., Herbison G.P. The long-term impact of the physical, emotional, and sexual abuse of children A community study . Child Abuse Negl. 20:1996;7-21.
69. Nemeroff C.B., Widerlöv E., Bisette G., Walleus H., Karlsson L., Eklund K., et al. Elevated concentrations of CSF corticotropin releasing factor like immunoreactivity in depressed patients. Science. 226:1984;1342-1344.
70. Nemeroff C.B., Owens M.J., Bisette G., Andorn A.C., Stanley M. Reduced corticotropin-releasing factor (CRF) binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry. 45:1988;577-579.
71. Nemeroff C.B., Bissette G., Akil H., Fink M. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Br J Psychiatry. 158:1992;59-63.
72. Nemeroff C.B., Krishnan R.R., Reed D., Leder R., Beam C., Dunnick N.R. Adrenal gland enlargement in major depression. Arch Gen Psychiatry. 49:1993;384-387.
73. Orth D.N., Kovacs W.J., deBold C.R. The adrenal cortex. Wilson J.D., Foster D.W. Williams Textbook of Endocrinology. 1992;489-619 Saunders, Philadelphia.
74. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev. 43:1991;425-473.
75. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression Focus on the serotonin transporter . Clin Chem. 40:1994;288-295.
76. Owens M.J., Bissette G., Nemeroff C.B. Acute effects of alprazolam on the concentrations of corticotropin-releasing factor in the rat brain. Synapse. 4:1989;196-202.
77. Pariante C.M., Nemeroff C.B., Miller A.H. Glucocorticoid receptors in depression. Isr J Med Sci. 31:1995;705-712.
78. Pich E.M., Koob O.F., Sattler S.C., Menzaghi F., Heilig M., Heinrichs S.C., et al. Stress-induced release of corticotropin-releasing factor in the maygdala measured by in vivo microdialysis. Neurosci Abstr. 18:1993;535.
79. Plotsky P.M., Meaney M.J. Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Mol Brain Res. 18:1993;195-200.
80. Plotsky PM, Thrivikraman KV, Caldji C, Sharma S, Meaney MJ (in press): The effects of neonatal rearing environment on CRF mRNA and CRF receptor levels in adult rat brain. J Neurosci.
81. Portegijs P.J.M., Jeuken F.M.H., van der Horst F.G., Kraan H.F., Knottnerus J.A. A troubled youth Relations with somatization, depression and anxiety in adulthood . Fam Pract. 13:1996;1-11.
82. Raadsheer F.C., Hoogendijk W.J., Stam F.C., Tilders F.J., Swaab D.F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 60:1994;436-444.
83. Raadsheer F.C., van Heerikhuize J.J., Lucassen P.J., Tilders F.J., Swaab D.F. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry. 152:1995;1372-1376.
84. Rosenbaum A.H., Maruta T., Schatzberg A.F., Orsulak P.J., Jiang N.S., Cole J.O., et al. Toward a biochemical classification of depressive disorders, VII Urinary free cortisol and urinary MHPG in depression . Am J Psychiatry. 140:1983;314-318.
85. Rosenblum S.A., Paully G.S. The effects of varying environmental demands on maternal and infant behavior. Child Dev. 55:1984;305-314.
86. Rosenblum L.A., Coplan J.D., Friedman S., Gorman J.M., Andrews M.W. Adverse early experiences affect noradrenergic and serotonergic functioning in adult primates. Biol Psychiatry. 35:1994;221-227.
87. Roy-Byrne P.P., Bierer L.M., Uhde T.W. The dexamethasone suppression test in panic disorder Comparison with normal control . Biol Psychiatry. 20:1985;1237-1240.
88. Roy-Byrne P.P., Uhde T.W., Post R.M., Gallucci W., Chrousos G.P., Gold P.W. The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry. 143:1986;896-899.
89. Saunders B.E., Villoponteaux L.A., Lipovsky J.A. Child sexual assault as a risk factor for mental disorders among women A community survey . J Interpers Violence. 7:1992;189-204.
90. Schreiber W., Lauer C.J., Krumrey K., Holsboer F., Krieg J.C. Dysregulation of the hypothalamic-pituitary-adrenal system in panic disorder. Neuropsychopharmacology. 15:1996;7-15.
91. Schulkin J., McEwen B.S., Gold P.W. Allostasis, the amygdala and anticipatory angst. Neurosci Biobeh Rev. 18:1994;1-12.
92. Schweizer E.E., Swenson C.M., Winokur A., Rickels K., Maislin G. The dexamethasone suppression test in generalized anxiety disorder. Br J Psychiatry. 149:1986;320-322.
93. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A. 93:1996;3908-3913.
94. Singewald N., Zhou G.Y., Chen F., Philippu A. Corticotropin-releasing factor modulates basal and stress-induced excitatory amino acid release in the locus coeruleus of conscious rats. Neurosci Lett. 204:1996;45-48.
95. Skutella T., Montkowski A., Stohr T., Probst J.C., Landgraf R., Holsboer F., et al. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social-defeat induced anxiety in rats. Cell Mol Neurobiol. 14:1994;579-588.
96. Smagin G.N., Harris R.B.S., Ryan D.H. Corticotropin-releasing factor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats. Neurosci Lett. 220:1996;167-170.
97. Smith M.A., Davidson M.A., Ritchie J.C., Kudler H., Lipper S., Chappell P., et al. The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. Biol Psychiatry. 26:1989;349-355.
98. Southwick S.M., Krystal J.H., Johnson D.R., Nagy L.M., Nicolau A., Heninger G.R., et al. Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry. 50:1993;266-274.
99. Stein M.B., Walker J.R., Anderson G., Hazen A.L., Ross C.A., Eldridge G., et al. Childhood physical and sexual abuse in patients with anxiety disorders in a community sample. Am J Psychiatry. 153:1996;275-277.
100. Stein M.B., Koverola C., Hanna C., Torchia M.G., McClarty B. Hippocampal volume in women victimized by childhood sexual abuse. Psychol Med. 27:1997;951-959.
101. Stokes P.E., Frazer A., Casper R. Unexpected neuroendocrine transmitter relationships. Psychopharmacol Bull. 17:1981;72-75.
102. Suomi S.J. Early stress and adult emotional reactivity in rhesus monkeys. Ciba Found Symp. 156:1991;171-183.
103. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain An immunohistochemical study . Neuroendocrinology. 36:1983;165-186.
104. Tancer M.E. Neurobiology of social phobia. J Clin Psychiatry. 54:1993;26-30.
105. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 213:1981;1394-1397.
106. Valentino R.J., Foote S.L., Aston-Jones G. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res. 270:1983;363-367.
107. van Bockstaele E.J., Colago E.E.O., Valentino R.J. Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J Comp Neurol. 364:1996;523-534.
108. van Oers H.J., DeKloet E.R., Levine S. Early versus late maternal deprivation differentially alters the endocrine and hypothalamic responses to stress. Brain Res. 111:1998;245-252.
109. Veith R.C., Lewis N., Langohr J.I., Murburg M.M., Ashleigh E.A., Castillo S., et al. Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects. Psychiatry Res. 46:1993;1-8.
110. von Bardeleben U., Holsboer F. Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression. J Neuroendocrinol. 1:1989;485-488.
111. Weiss J.M., Stout J.C., Aaron M., Owens M.J., Nemeroff C.B. Experimental studies of anxiety and depression Locus coeruleus and corticotropin-releasing factor . Brain Res Bull. 35:1994;561-572.
112. Widerlöv E., Bissette G., Nemeroff C.B. Monoamine metabolites, corticotropin-releasing factor and somatostatin as CSF markers in depressed patients. J Affect Disord. 14:1988;99-107.
113. Workel J.O., Oitzl M.S., Ledeboer A., DeKloet E.R. The Brown Norway rat displays enhanced stress-induced ACTH reactivity at day 18 after 24 h maternal deprivation at day 3. Brain Res. 103:1997;199-203.
114. Yehuda R. Sensitization of the hypothalamic-pituitary-adrenal axis in posttraumatic stress disorder. Ann N Y Acad Sci. 821:1997;57-75.
115. Yehuda R., Lowy M.T., Southwick S.M., Shaffer D., Giller E.L. Increased number of glucocorticoid receptor in posttraumatic stress disorder. Am J Psychiatry. 148:1991;499-504.
116. Yehuda R., Boisoneau D., Mason J., Giller E.L. Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders. Biol Psychiatry. 34:1993;18-25.
117. Yehuda R., Southwick S.M., Krystal J.H., Bremner D.J., Charney D.S., Mason J.W. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry. 150:1993;83-86.
118. Yehuda R., Boisoneau D., Lowy M.T., Giller E.L. Dose-response changes in plasma cortisol and lymphocyte glu-cocorticoid receptors following dexamethasone administra-tion in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry. 52:1995;538-593.
119. Yehuda R., Levengood R.A., Schmeidler J., Wilson S., Guo L.S., Gerber D. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder. Psychoneuroendocrinology. 21:1996;1-16.
120. Yehuda R., Teicher R.L., Trestman R., Siever L.J. Cortisol regulation in posttraumatic stress disorder and major depres-sion A chronobiological analysis . Biol Psychiatry. 40:1996;79-88.
121. Young E.A., Abelson J.L., Curtis G.C., Nesse R.M. Childhood adversity and vulnerability to mood and anxiety disorders. Depression Anx. 5:1997;66-72.
122. Zaidi L.Y., Foy D.W. Childhood abuse experiences and combat related PTSD. J Traum Stress. 7:1993;33-42.
123. Zlotnick C., Ryan C.E., Miller I.W., Keitner G.I. Childhood abuse and recovery from major depression. Child Abuse Negl. 19:1995;1513-1516.